One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the DANBIO registry

Bente Glintborg; I J Sørensen; E.  Omerovic; F. Mehnert; N Manilo; Kamilla Danebod; Dorte Vendelbo Jensen; Henrik Nordin; Anne Gitte Loft; Oliver Hendricks; S. Chrysidis; B. L. Andersen; Johnny Lillelund Raun; Hanne Lindegaard; Jakob Espesen; S. H. Jakobsen; Inger Marie Jensen Hansen; E. B.  Dalsgaard; D. D. Pedersen; S. Kristensen; Asta Linauskas; L. S.  Andersen; J Grydehøj; N. Krogh; Merete Lund Hetland

One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the DANBIO registry

Bente Glintborg
, I J Sørensen
, E. Omerovic
, F. Mehnert
, N Manilo
, Kamilla Danebod
, Dorte Vendelbo Jensen
, Henrik Nordin
, Anne Gitte Loft
, Oliver Hendricks
, S. Chrysidis
, B. L. Andersen
, Johnny Lillelund Raun
, Hanne Lindegaard
, Jakob Espesen
, S. H. Jakobsen
, Inger Marie Jensen Hansen
, E. B. Dalsgaard
, D. D. Pedersen
, S. Kristensen

Asta Linauskas, L. S. Andersen, J Grydehøj, N. Krogh, Merete Lund Hetland

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	THU0189
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	77
Udgave nummer	Suppl. 2
Sider (fra-til)	313-314
Antal sider	2
ISSN	0003-4967
Status	Udgivet - jun. 2018
Begivenhed	EULAR 2018 - Amsterdam, Holland Varighed: 13. jun. 2018 → 16. jun. 2018

Konference

Konference	EULAR 2018
Land/Område	Holland
By	Amsterdam
Periode	13/06/2018 → 16/06/2018

Dokumenter og links

https://ard.bmj.com/content/77/Suppl_2/313

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Glintborg, B., Sørensen, I. J., Omerovic, E., Mehnert, F., Manilo, N., Danebod, K., Jensen, D. V., Nordin, H., Loft, A. G., Hendricks, O., Chrysidis, S., Andersen, B. L., Lillelund Raun, J., Lindegaard, H., Espesen, J., Jakobsen, S. H., Jensen Hansen, I. M., Dalsgaard, E. B., Pedersen, D. D., ... Hetland, M. L. (2018). One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the DANBIO registry. Annals of the Rheumatic Diseases, 77(Suppl. 2), 313-314. Artikel THU0189. https://ard.bmj.com/content/77/Suppl_2/313

@article{c84ac887c41246b688dd2708ae8f8844,

title = "One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the DANBIO registry",

author = "Bente Glintborg and S{\o}rensen, \{I J\} and E. Omerovic and F. Mehnert and N Manilo and Kamilla Danebod and Jensen, \{Dorte Vendelbo\} and Henrik Nordin and Loft, \{Anne Gitte\} and Oliver Hendricks and S. Chrysidis and Andersen, \{B. L.\} and \{Lillelund Raun\}, Johnny and Hanne Lindegaard and Jakob Espesen and Jakobsen, \{S. H.\} and \{Jensen Hansen\}, \{Inger Marie\} and Dalsgaard, \{E. B.\} and Pedersen, \{D. D.\} and S. Kristensen and Asta Linauskas and Andersen, \{L. S.\} and J Grydeh{\o}j and N. Krogh and Hetland, \{Merete Lund\}",

year = "2018",

month = jun,

language = "English",

volume = "77",

pages = "313--314",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier",

number = "Suppl. 2",

note = "EULAR 2018 ; Conference date: 13-06-2018 Through 16-06-2018",

}

Glintborg, B, Sørensen, IJ, Omerovic, E, Mehnert, F, Manilo, N, Danebod, K, Jensen, DV, Nordin, H, Loft, AG, Hendricks, O, Chrysidis, S, Andersen, BL, Lillelund Raun, J, Lindegaard, H, Espesen, J, Jakobsen, SH, Jensen Hansen, IM, Dalsgaard, EB, Pedersen, DD, Kristensen, S, Linauskas, A, Andersen, LS, Grydehøj, J, Krogh, N & Hetland, ML 2018, 'One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the DANBIO registry', Annals of the Rheumatic Diseases, bind 77, nr. Suppl. 2, THU0189, s. 313-314. <https://ard.bmj.com/content/77/Suppl_2/313>

One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the DANBIO registry. / Glintborg, Bente; Sørensen, I J; Omerovic, E. et al.
I: Annals of the Rheumatic Diseases, Bind 77, Nr. Suppl. 2, THU0189, 06.2018, s. 313-314.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the DANBIO registry

AU - Glintborg, Bente

AU - Sørensen, I J

AU - Omerovic, E.

AU - Mehnert, F.

AU - Manilo, N

AU - Danebod, Kamilla

AU - Jensen, Dorte Vendelbo

AU - Nordin, Henrik

AU - Loft, Anne Gitte

AU - Hendricks, Oliver

AU - Chrysidis, S.

AU - Andersen, B. L.

AU - Lillelund Raun, Johnny

AU - Lindegaard, Hanne

AU - Espesen, Jakob

AU - Jakobsen, S. H.

AU - Jensen Hansen, Inger Marie

AU - Dalsgaard, E. B.

AU - Pedersen, D. D.

AU - Kristensen, S.

AU - Linauskas, Asta

AU - Andersen, L. S.

AU - Grydehøj, J

AU - Krogh, N.

AU - Hetland, Merete Lund

PY - 2018/6

Y1 - 2018/6

M3 - Conference abstract in journal

SN - 0003-4967

VL - 77

SP - 313

EP - 314

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl. 2

M1 - THU0189

T2 - EULAR 2018

Y2 - 13 June 2018 through 16 June 2018

ER -